CRISPR/Cas9 for the Correction of Mutated Dystrophin Gene
Year: 2016
Type: dissertation
Abstract: Introduction: The recent discovery of a CRISPR/Cas adaptive immunity in bacteria and archaea has led to the development of a eukaryotic-optimized RNA-guided Cas9 system, which has various potential clinical applications. Amongst candidate diseases is X-linked recessive Duchenne Muscular Dystrophy, a degenerative muscular disease that leads to muscle wasting and limited life span. \nAim: The overall main aim of this project was to induce a frame-shift in the DMD gene using CRISPR/Cas9 in hope to restore a lost reading frame resulting from deletion of exons 8-12. Specific aims of the Master´s project were to locate deletion breakpoints, design the CRISPR/Cas system and to get a viable cell lineage from a subject for experimental testing. \nMethods: Deletion breakpoint in the DMD gene were mapped in the subject using Comparative Genomic Hybridization microarray and Polymerase Chain Reaction with Sanger sequencing. Whole Genome sequencing of the subject genome were obtained by deCODE. The CRISPR/Cas9 system was designed to target the genome using various softwares. Expression vectors for the system were transformed into E.coli DH5α cells. Immortalized myoconverted fibroblasts were derived from the subject in collaboration with the AFM-Myobank and expanded. Transfection was done with lipofection (Viafect). \nResults: Analysis of the location of the breakpoint showed that the location was inside a fused 7/12 intron, and the estimated DNA deletion size was around 196 kb. A transformation efficiency of 1.5 x 107 cfu/μg was obtained in the E.coli DH5α cells. The observed transfection efficiency of myoconverted fibroblast was 5% and lowest toxic dose of blasticidin S was 3 μg/ml. \nDiscussion/Conclusion: The results will be useful in future experiments to correct the DMD gene by frame shift with short indels at the repaired cut site. This project will add valuable specific and general knowledge to genome editing can in treating genetic disease.
Source: Skemman
Author: Priyanka Thapa Manger
Institution: University of Iceland
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2751168047
